Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Payers' Guide
Payers' Guide
,
FDA Approvals
Jentadueto: A New Oral Antihyperglycemic Combination Therapy for Patients with Type 2 Diabetes
Wayne Kuznar, Medical Writer
Read More
Payers' Guide
,
FDA Approvals
Abraxane Receives New Indication for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer When Curative Surgery or Radiation Therapy Is Not an Option
Lynne Lederman, PhD
Read More
FDA Approvals
,
Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2012
Read More
FDA Approvals
,
Payers' Guide
Foreword: The Fourth Annual Payers’ Guide to New FDA Approvals
Read More
FDA Approvals
,
Payers' Guide
Introduction: New FDA Drug Approvals in 2012: A 15-Year High
Gary M. Owens, MD
Read More
16
17
18
19
Page 19 of 19
Results 181 - 185 of 185